PSMA-RGS is an emerging approach that shows promise for improving lymph node assessment and treatment outcomes in prostate cancer. However, its effect on cancer-specific as well as overall survival are still being investigated, and PSMA-targeted surgery remains an area of active research.
Keyphrases
- lymph node
- prostate cancer
- minimally invasive
- pet ct
- coronary artery bypass
- radical prostatectomy
- pet imaging
- neoadjuvant chemotherapy
- sentinel lymph node
- surgical site infection
- papillary thyroid
- cancer therapy
- big data
- radiation therapy
- squamous cell carcinoma
- drug delivery
- mass spectrometry
- deep learning
- atrial fibrillation
- artificial intelligence